UNUSUAL CASES IN PERITONEAL SURFACE MALIGNANCIES

1. Peritoneal Metastasis from Small Bowel Adenocarcinoma Associated with Crohn’s Disease
2. Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
3. Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites
4. Unusual Indications of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Review of Outcomes and Report of the Literature
5. Management of Desmoplastic Small Round Cell Tumor
6. Peritoneal Metastasis of Retroperitoneal Tumors
7. Management of Peritoneal Metastasis from Uterine Sarcoma
8. The Role of Surgery and Tyrosine Kinase Inhibitors in the Management of Advanced or Recurrent GIST
9. Treatment of Peritoneal Metastases from Breast Cancer by Maximal Cytoreduction and HIPEC
10. Benign Types of Peritoneal Mesothelioma

This book has been designed to provide the full description of the comprehensive management of peritoneal surface malignancies which have originated from different primaries, such as breast cancer, small bowel cancers and imatinib resistant GISTosis and sarcomas and pseudomyxoma. The book provides the most up-to-date information on current approaches such as cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Given the increasing evidence that the patients who may benefit from this treatment modality avoid potential lethal course of these diseases, the book explores the application of these approaches to a number of types of malignancy.
The first chapters explore Benign Multicystic Mesothelioma and Pseudomyxoma Peritonei arising from unusual primaries. Among other explored topics are peritoneal metastases from serous papillary uterine carcinoma, sarcoma and from unusual origins.
This book is valuable for surgical oncologists who deal with the management of peritoneal surface malignancies.

Features
• Provides the full description of the management of peritoneal surface malignancies originated from different and unusual miscellaneous tumours
• Chapters explore cytoreductive surgery and HIPEC, which are becoming a standard of care for the management of benign multicystic mesothelioma
• The authors provide the reader with their own experiences in special cases

Author
Emel Canbay has a MD from Cumhuriyet University (Turkey) and PhD from University of London King's College School of Medicine and Dentistry (UK). She has had fellowships from the University of Bristol (UK); the International Centre for Genetic Engineering and Biotechnology (Italy); and Imperial Cancer Research Fund (London, UK). She has a speciality in General Surgery from Ankara, Turkey. She has been assigned from the Ministry of Health of Turkey as an attending surgeon to the Breast Units and Gastrointestinal Surgery, and Accident and Emergency Departments of Istanbul University, Istanbul Medical Faculty and Istanbul Cerrahpasa Medical Faculty for four years. She had a clinical fellowship from Peritoneal Cancer Centre in Osaka- Japan under the supervision of Dr. Yutaka Yonemura. She has completed surgical and clinical follow up over the 200 cases with peritoneal metastases in Japan. She has been working as Head of the Peritoneal Malignancy Centre and Non Profit Organization for Hyperthermic Intraperitoneal Chemotherapy (Istanbul, Turkey) since 2013.